Metraipolis › archive › dc_dcd255793631
Cardiotoxicity of newer HER2-Directed therapies in breast cancer: A systematic review and meta-analysis of incidence and comparative risk — Europe PMC PMID:42520572
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42520572
- DOI
- 10.1016/j.breast.2026.104880
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-18T03:57:47.087Z
- SHA-256 of the archived text
dd0215a1c152679178d1bbad4baf36ccf43aedae4048fb3a16b65194a2dba7d9- Stable URL of this page
https://metraipolis.com/documento/dc_dcd255793631
How to cite
Cardiotoxicity of newer HER2-Directed therapies in breast cancer: A systematic review and meta-analysis of incidence and comparative risk — Europe PMC PMID:42520572 — Europe PMC (en), https://europepmc.org/article/MED/42520572 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_dcd255793631 (Metraipolis archive dc_dcd255793631, sha256 dd0215a1c152679178d1bbad4baf36ccf43aedae4048fb3a16b65194a2dba7d9)
BibTeX
@misc{dcdcd255793631,
title = {Cardiotoxicity of newer HER2-Directed therapies in breast cancer: A systematic review and meta-analysis of incidence and comparative risk — Europe PMC PMID:42520572},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42520572},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_dcd255793631; sha256 dd0215a1c152679178d1bbad4baf36ccf43aedae4048fb3a16b65194a2dba7d9},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42520572. Agents can read the archived copy with the MCP tool read_document.